Maximilien Fleron
University of Liège
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maximilien Fleron.
Journal of Proteomics | 2010
Maximilien Fleron; Yannick Greffe; Davide Musmeci; Anne-Cécile Massart; Vincent Hennequière; Gabriel Mazzucchelli; David Waltregny; M. C. De Pauw-Gillet; Vincenzo Castronovo; E. De Pauw; Andrei Turtoi
In the field of proteomics there is an apparent lack of reliable methodology for quantification of posttranslational modifications. Present study offers a novel post-digest ICPL quantification strategy directed towards characterization of phosphorylated and glycosylated proteins. The value of the method is demonstrated based on the comparison of two prostate related metastatic cell lines originating from two distinct metastasis sites (PC3 and LNCaP). The method consists of protein digestion, ICPL labeling, mixing of the samples, PTM enrichment and MS-analysis. Phosphorylated peptides were isolated using TiO(2), whereas the enrichment of glycosylated peptides was performed using hydrazide based chemistry. Isolated PTM peptides were analyzed along with non enriched sample using 2D-(SCX-RP)-Nano-HPLC-MS/MS instrumentation. Taken together the novel ICPL labeling method offered a significant improvement of the number of identified (∼600 individual proteins) and quantified proteins (>95%) in comparison to the classical ICPL method. The results were validated using alternative protein quantification strategies as well as label-free MS quantification method. On the biological level, the comparison of PC3 and LNCaP cells has shown specific modulation of proteins implicated in the fundamental process related to metastasis dissemination. Finally, a preliminary study involving clinically relevant autopsy cases reiterated the potential biological value of the discovered proteins.
Proteome Science | 2008
Gabriel Mazzucchelli; Valérie Gabelica; Nicolas Smargiasso; Maximilien Fleron; Wilson Ashimwe; Frédéric Rosu; Marie-Claire De Pauw-Gillet; Jean-François Riou; Edwin De Pauw
BackgroundTelomerase confers cellular immortality by elongating telomeres, thereby circumventing the Hayflick limit. Extended-life-span cells have been generated by transfection with the human telomerase reverse transcriptase (hTERT) gene. hTERT transfected cell lines may be of outstanding interest to monitor the effect of drugs targeting the telomerase activity. The incidence of hTERT gene transfection at the proteome level is a prerequisite to that purpose. The effect of the transfection has been studied on the proteome of human fibroblast (WI38). Cytosolic and nuclear fractions of WI38 cells, empty vector transfected WI38 (WI38-HPV) and hTERT WI38 cells were submitted to a 2D-DIGE (Two-Dimensional Differential In-Gel Electrophoresis) analysis. Only spots that had a similar abundance in WI38 and WI38-HPV, but were differentially expressed in WI38 hTERT were selected for MS identification. This method directly points to the proteins linked with the hTERT expression. Number of false positive differentially expressed proteins has been excluded by using control WI38-HPV cells. The proteome alteration induced by hTERT WI38 transfection should be taken into account in subsequent use of the cell line for anti-telomerase drugs evaluation.Results2D-DIGE experiment shows that 57 spots out of 2246 are significantly differentially expressed in the cytosolic fraction due to hTERT transfection, and 38 were confidently identified. In the nuclear fraction, 44 spots out of 2172 were selected in the differential proteome analysis, and 14 were identified. The results show that, in addition to elongating telomeres, hTERT gene transfection has other physiological roles, among which an enhanced ER capacity and a potent cell protection against apoptosis.ConclusionWe show that the methodology reduces the complexity of the proteome analysis and highlights proteins implicated in other processes than telomere elongation. hTERT induced proteome changes suggest that telomerase expression enhances natural cell repair mechanisms and stress resistance probably required for long term resistance of immortalized cells. Thus, hTERT transfected cells can not be only consider as an immortal equivalent to parental cells but also as cells which are over-resistant to stresses. These findings are the prerequisite for any larger proteomics aiming to evaluate anti-telomerase drugs proteome alteration and thus therapeutics induced cell reactions.
Micron | 2013
Daureen Schol; Maximilien Fleron; Jean-François Greisch; Michael Jaeger; Martin Frenz; E. De Pauw; M. C. De Pauw-Gillet
While cancer is one of the greatest challenges to public health care, prostate cancer was chosen as cancer model to develop a more accurate imaging assessment than those currently available. Indeed, an efficient imaging technique which considerably improves the sensitivity and specificity of the diagnostic and predicting the cancer behavior would be extremely valuable. The concept of optoacoustic imaging using home-made functionalized gold nanoparticles coupled to an antibody targeting PSMA (prostate specific membrane antigen) was evaluated on different cancer cell lines to demonstrate the specificity of the designed platform. Two commonly used microscopy techniques (indirect fluorescence and scanning electron microscopy) showed their straightforwardness and versatility for the nanoparticle binding investigations regardless the composition of the investigated nanoobjects. Moreover most of the research laboratories and centers are equipped with fluorescence microscopes, so indirect fluorescence using Quantum dots can be used for any active targeting nanocarriers (polymers, ceramics, metals, etc.). The second technique based on backscattered electron is not only limited to gold nanoparticles but also suits for any study of metallic nanoparticles as the electronic density difference between the nanoparticles and binding surface stays high enough. Optoacoustic imaging was finally performed on a 3D cellular model to assess and prove the concept of the developed platform.
Archive | 2007
Maximilien Fleron; Daureen Schol; Jean-François Greisch; Edwin De Pauw; Marie-Claire De Pauw-Gillet
Archive | 2013
Rémi Longuespée; Céline Piron; Maximilien Fleron; Marie-Claire De Pauw-Gillet; Philippe Delvenne; Edwin De Pauw
Archive | 2012
Daureen Schol; Maximilien Fleron; Marie-Claire De Pauw-Gillet; Edwin De Pauw
Archive | 2010
Maximilien Fleron; Yannick Greffe; Anne-Cécile Massart; Vincent Hennequière; Davide Musmeci; Gabriel Mazzucchelli; Marie-Claire De Pauw-Gillet; Vincenzo Castronovo; Edwin De Pauw; Andrei Turtoi
Archive | 2008
Daureen Schol; Maximilien Fleron; Jean-François Greisch; Marie-Claire De Pauw-Gillet; Edwin De Pauw; Michael Jaeger; Martin Frenz; Sue Eccles; Jeffrey C. Bamber; Stefano Frosini; Leonardo Massotti; Marc Fournelle; Robert Lemor
Anticancer Research | 2008
Daureen Schol; Maximilien Fleron; Jean François Greisch; Marie-Claire De Pauw-Gillet; Edwin De Pauw; Michael Jaeger; Martin Frenz; Sue Eccles; Jeffrey C. Bamber; S. Frozini; L. Masotti; Marc Fournelle; Robert Lemor
Archive | 2007
Maximilien Fleron; Daureen Schol; Jean-François Greisch; Edwin De Pauw; Marie-Claire De Pauw-Gillet